Article Details
Retrieved on: 2021-04-13 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
British-Swedish pharma giant, AstraZeneca, has disclosed key preclinical data for AZD5305, its next-generation PARP1 selective inhibitor at the virtual ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here